Schizophrenia - Treatment Options, Symptoms, Causes & Diagnosis from MedifocusHealth

Schizophrenia > What Your Doctor is Reading About Schizophrenia > Drug Therapy

Drug Therapy

1. Atypical antipsychotic drugs: current issues of safety and efficacy in the management of schizophrenia.

Author: Vohora D;
Institution: Jamia Hamdard (Hamdard University), Faculty of Pharmacy, Department of Pharmacology, New Delhi 110062, India. divyavohora@hotmail.com
Journal: Curr Opin Investig Drugs. 2007 Jul;8(7):531-8.
Abstract URL: Click here to view abstract

2. The attitude of patients towards antipsychotic depot treatment.

Author: Heres S; Schmitz FS; Leucht S; Pajonk FG;
Institution: aKlinik und Poliklinik fuer Psychiatrie und Psychotherapie, Technical University Munich bDepartment of Psychiatry and Psychotherapy, The Saarland University Hospitals, Homburg/Saar.
Journal: Int Clin Psychopharmacol. 2007 Sep;22(5):275-82.
Abstract URL: Click here to view abstract

3. No effect of donepezil on neurocognition and social cognition in young persons with stable schizophrenia.

Author: Kohler CG; Martin EA; Kujawski E; Bilker W; Gur RE; Gur RC; Kohler CG; Martin EA; Kujawski E; Bilker W; Gur RE; Gur RC;
Institution: Schizophrenia Research Center, Neuropsychiatry Section, University of Pennsylvania, Philadelphia, PA, USA.
Journal: Cognit Neuropsychiatry. 2007 Sep;12(5):412-21.
Abstract URL: Click here to view abstract

4. Treatment with amisulpride and olanzapine improve neuropsychological function in schizophrenia.

Author: Mortimer AM; Joyce E; Balasubramaniam K; Choudhary PC; Saleem PT;
Institution: University of Hull, Hull, UK.
Journal: Hum Psychopharmacol. 2007 Aug 9;.
Abstract URL: Click here to view abstract

5. Novel targets for drugs in schizophrenia.

Author: Stone JM; Pilowsky LS;
Institution: Section of Neurochemical Imaging, Kings College London Institute of Psychiatry, De Crespigny Park, London, SE5 8AF, UK. j.stone@iop.kcl.ac.uk.
Journal: CNS Neurol Disord Drug Targets. 2007 Aug;6(4):265-72.
Abstract URL: Click here to view abstract

6. Clozapine-induced hypersalivation: a review of treatment strategies.

Author: Sockalingam S; Shammi C; Remington G;
Institution: Department of Psychiatry, University of Toronto, Ontario. Sanjeev_Sockalingam@camh.net
Journal: Can J Psychiatry. 2007 Jun;52(6):377-84.
Abstract URL: Click here to view abstract

7. How effective is it to sequentially switch among Olanzapine, Quetiapine and Risperidone?-A randomized, open-label study of algorithm-based antipsychotic treatment to patients with symptomatic schizophrenia in the real-world clinical setting.

Author: Suzuki T; Uchida H; Watanabe K; Nomura K; Takeuchi H; Tomita M; Tsunoda K; Nio S; Den R; Manki H; Tanabe A; Yagi G; Kashima H;
Institution: Department of Neuro-Psychiatry, School of Medicine, Keio University, 35, Shinanomachi, Shinjuku-ku, Tokyo, 160-8582, Japan, takefumi@oak.dti.ne.jp.
Journal: Psychopharmacology (Berl). 2007 Aug 14;.
Abstract URL: Click here to view abstract

8. Outcome following clozapine discontinuation: a retrospective analysis.

Author: Atkinson JM; Douglas-Hall P; Fischetti C; Sparshatt A; Taylor DM;
Institution: South London and Maudsley National Health Service (NHS) Trust, Pharmacy Department, Maudsley Hospital, London, United Kingdom. jamesatkinson@nhs.net
Journal: J Clin Psychiatry. 2007 Jul;68(7):1027-30.
Abstract URL: Click here to view abstract

9. Monitored Naltrexone without Counseling for Alcohol Abuse/Dependence in Schizophrenia-Spectrum Disorders.

Author: Batki SL; Dimmock JA; Wade M; Gately PW; Cornell M; Maisto SA; Carey KB; Ploutz-Snyder R;
Institution: Department of Psychiatry, SUNY Upstate Medical University, Syracuse, New York.
Journal: Am J Addict. 2007 Jul-Aug;16(4):253-9.
Abstract URL: Click here to view abstract

10. Comparison of olanzapine to risperidone in substance-abusing individuals with schizophrenia.

Author: Akerele E; Levin FR;
Institution: Department of Psychiatry, Harlem Hospital, College of Physicians and Surgeons of Columbia University, New York, New York.
Journal: Am J Addict. 2007 Jul-Aug;16(4):260-8.
Abstract URL: Click here to view abstract

11. Long-acting injectable risperidone for the treatment of schizophrenia : clinical perspectives.

Author: Moller HJ;
Institution: Department of Psychiatry, Ludwig-Maximilians-University, Munich, Germany.
Journal: Drugs. 2007;67(11):1541-66.
Abstract URL: Click here to view abstract

12. The effectiveness of ziprasidone in treating impaired quality of life in schizophrenia: A 12-month, open-label, flexible-dose, naturalistic observational study of patients undergoing usual care.

Author: Ritsner MS; Yorkov V; Ratner Y; Soifer P; Gibel A;
Institution: Sha'ar Menashe Mental Health Center, Mobile Post Hefer 38814, Israel; Rappaport Faculty of Medicine, Technion - Israel Institute of Technology, Haifa, Israel.
Journal: Prog Neuropsychopharmacol Biol Psychiatry. 2007 Jul 4;.
Abstract URL: Click here to view abstract

13. Effectiveness, safety, and tolerability of ziprasidone for treating schizophrenia patients undergoing usual care: A 12-month, open-label, flexible-dose, naturalistic observational trial.

Author: Ratner Y; Gibel A; Yorkov V; Ritsner MS;
Institution: Acute Department, Sha'ar Menashe Mental Health Center, Mobile Post Hefer 38814, Hadera, Israel.
Journal: Prog Neuropsychopharmacol Biol Psychiatry. 2007 Jun 21;.
Abstract URL: Click here to view abstract

14. Antipsychotic Medication for Childhood-Onset Schizophrenia.

Author: Kennedy E; Kumar A; Datta SS;
Institution: 2Child and Family Department, Tavistock Clinic, 120 Belsize Lane, London NW3 5BA, UK.
Journal: Schizophr Bull. 2007 Aug 1;.

15. Gender differences in response to antipsychotic treatment in outpatients with schizophrenia.

Author: Usall J; Suarez D; Haro JM;
Institution: Sant Joan de Deu-Serveis de Salut Mental, Fundacio Sant Joan de Deu, Sant Boi de Llobregat, Barcelona, Spain.
Journal: Psychiatry Res. 2007 Aug 1;.
Abstract URL: Click here to view abstract

16. Agitation associated with aripiprazole initiation.

Author: Lea JW; Stoner SC; Lafollette J;
Institution: 1 University of Missouri-Kansas City School of Pharmacy, Kansas City, Missouri; Northwest Missouri Psychiatric Rehabilitation Center, St. Joseph, Missouri.
Journal: Pharmacotherapy. 2007 Sep;27(9):1339-42.
Abstract URL: Click here to view abstract

17. Pharmacogenetics and schizophrenia.

Author: Foster A; Miller del D; Buckley PF;
Institution: Department of Psychiatry and Health Behavior, Medical College of Georgia, Augusta, GA 30912, USA. afoster@mcg.edu <afoster@mcg.edu>
Journal: Psychiatr Clin North Am. 2007 Sep;30(3):417-35.
Abstract URL: Click here to view abstract

18. Prevalence of the metabolic syndrome among patients receiving clozapine.

Author: Lamberti JS; Olson D; Crilly JF; Olivares T; Williams GC; Tu X; Tang W; Wiener K; Dvorin S; Dietz MB;
Institution: Department of Psychiatry, University of Rochester Medical Center, 300 Crittenden Blvd., Rochester, NY 14642, USA. steve_lamberti@urmc.rochester.edu
Journal: Am J Psychiatry. 2006 Jul;163(7):1273-6.
Abstract URL: Click here to view abstract

19. Association of initial antipsychotic response to clozapine and long-term weight gain.

Author: Bai YM; Lin CC; Chen JY; Lin CY; Su TP; Chou P;
Institution: Community Medicine Research Center and Institute of Public Health, National Yang-Ming University,155 Li-Nong St., Sec. 2, Shihpai, Taipei 112, Taiwan.
Journal: Am J Psychiatry. 2006 Jul;163(7):1276-9.
Abstract URL: Click here to view abstract

20. The choice of drugs for schizophrenia.

Author: Davis JM;
Institution
Journal: N Engl J Med. 2006 Feb 2;354(5):518-20.

21. Antipsychotic medications: metabolic and cardiovascular risk.

Author: Newcomer JW;
Institution: Department of Psychiatry, Center for Clinical Studies, Washington University School of Medicine, St. Louis, Mo, USA. newcomerj@wustl.edu
Journal: J Clin Psychiatry. 2007;68 Suppl 4:8-13.
Abstract URL: Click here to view abstract

22. Switching antipsychotics as a treatment strategy for antipsychotic-induced weight gain and dyslipidemia.

Author: Weiden PJ;
Institution: State University of New York (SUNY) Downstate Medical Center and King's County Hospital, Brooklyn, N.Y., USA. pjweiden@msn.com
Journal: J Clin Psychiatry. 2007;68 Suppl 4:34-9.
Abstract URL: Click here to view abstract

23. Risk of extrapyramidal syndrome in schizophrenic patients treated with antipsychotics: a population-based study.

Author: Yang SY; Kao Yang YH; Chong MY; Yang YH; Chang WH; Lai CS;
Institution: Graduate Institute of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.
Journal: Clin Pharmacol Ther. 2007 Apr;81(4):586-94. Epub 2007 Jan 18.
Abstract URL: Click here to view abstract